Results 1 to 10 of about 1,529,288 (217)
The Use of Fibrinolytic Agents in the Salvage of Free Flaps: A Systematic Review [PDF]
Background: Microvascular thrombosis following free tissue transfer presents a complex challenge for surgeons and carries the potential risk of flap failure. The application of fibrinolytic agents represents a robust therapeutic option.
Christian Smolle +2 more
exaly +3 more sources
Combining antithrombotic and fibrinolytic agents: can it be done? [PDF]
More than half of ischemic stroke patients who are treated with IV recombinant tissue-type plasminogen activator (rtPA) remain disabled at 3 months.1,2 The reasons are many. The IV rtPA rate of recanalizing occluded arteries is not as high as we would like, especially for large arterial occlusions, which are opened only 30% to 40% of the time.3–6 When ...
Khatri P, Mono ML.
europepmc +4 more sources
Cardiovascular disease is among the largest contributors of premature mortality in the world caused by inflammation of blood vessels. The abnormalities provoke thrombus formation or thrombosis blocking blood vessels leading to strokes, heart attacks and ...
Fuad Hayatun +9 more
doaj +2 more sources
Fibrinolytic agents for peripheral arterial occlusion. [PDF]
Peripheral arterial thrombolysis is used in the management of peripheral arterial ischaemia. Streptokinase was originally used but safety concerns led to a search for other agents. Urokinase and recombinant tissue plasminogen activator (rt-PA) have increasingly become established as first line agents for peripheral arterial thrombolysis.
Robertson I, Kessel DO, Berridge DC.
europepmc +4 more sources
Intrapleural Fibrinolytic Therapy in the Management of Pediatric Pleural Empyema: A Narrative Review [PDF]
Background: Pediatric pleural empyema is a major complication of community-acquired pneumonia and remains associated with substantial morbidity despite advances in vaccination, antimicrobial therapy, and supportive care. Intrapleural fibrinolytic therapy
Susanna Esposito +3 more
doaj +2 more sources
Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
BackgroundAcute lung injury (ALI) is characterized by suppressed fibrinolytic activity in bronchoalveolar lavage fluid (BALF) attributed to elevated plasminogen activator inhibitor-1 (PAI-1).
Cong Liu +12 more
doaj +3 more sources
Enhanced Production of Fibrinolytic Enzyme from Pseudomonas aeruginosa by Optimization Media Components [PDF]
Fibrinolytic enzyme is factor that lysis fibrin clots. This fibrinolytic factor has prospective use to treat cardiovascular diseases, such as stroke and heart attack. Cardiovascular diseases attracted worldwide attention for their elevation morbidity and
Bilal Jasim, Entesar Ali
doaj +1 more source
Cardiovascular diseases (CVDs) have emerged as a major threat to global health resulting in a decrease in life expectancy with respect to humans. Thrombosis is one of the foremost causes of CVDs, and it is characterized by the unwanted formation of ...
Noora Barzkar +2 more
doaj +1 more source
Plant-Derived Compounds and Extracts as Modulators of Plasmin Activity—A Review
Functionality of the fibrinolytic system is based on activity of its central enzyme, plasmin, responsible for the removal of fibrin clots. Besides the hemostasis, fibrinolytic proteins are also involved in many other physiological and pathological ...
Joanna Kolodziejczyk-Czepas, Jan Czepas
doaj +1 more source
In the entire world, cardiovascular diseases (CVDs) are the main cause of death. For the treatment of CVDs, microbial fibrinolytic enzymes are highly regarded as novel therapeutic candidates.
Rebhika Lusiana +2 more
doaj +1 more source

